NiKang Therapeutics
Jiping Fu has a long history of work experience in the field of chemistry. Jiping began their career in 2003 as a postdoc at Harvard University. In 2004, they became a Research Investigator II at Novartis Institutes for BioMedical Research, Inc. Jiping then moved up to become a Research Investigator III in 2007 and a Senior Investigator I in 2017. In 2018, they became an Executive Director of Chemistry at Nikang Therapeutics, Inc. and was promoted to Vice President of Chemistry in 2020.
Jiping Fu received a Ph. D in Organic Chemistry from the University of Illinois Urbana-Champaign in 2002. Prior to that, they attended the University of Science and Technology of China.
This person is not in any offices
NiKang Therapeutics
NiKang Therapeutics, Inc. is a privately-held biotech company focused on developing novel small molecule oncology drug discovery. Their mission is to discover and develop first-in-class, and/or best-in-class small molecule targeted therapies and immuno-oncology (I-O) drugs to help cure cancers.